| Literature DB >> 33263204 |
Jin Wang1, Yinhang Jia2, Qiyue Wang1, Zeyu Liang1,3, Guangxu Han2, Zejun Wang2, Jiyoung Lee1, Meng Zhao1,3, Fangyuan Li1, Ruiliang Bai2,4,5, Daishun Ling1,4,3.
Abstract
The assessment of vascular anatomy and functions using magnetic resonance imaging (MRI) is critical for medical diagnosis, whereas the commonly used low-field MRI system (≤3 T) suffers from low spatial resolution. Ultrahigh field (UHF) MRI (≥7 T), with significantly improved resolution and signal-to-noise ratio, shows great potential to provide high-resolution vasculature images. However, practical applications of UHF MRI technology for vascular imaging are currently limited by the low sensitivity and accuracy of single-mode (T1 or T2 ) contrast agents. Herein, a UHF-tailored T1 -T2 dual-mode iron oxide nanoparticle-based contrast agent (UDIOC) with extremely small core size and ultracompact hydrophilic surface modification, exhibiting dually enhanced T1 -T2 contrast effect under the 7 T magnetic field, is reported. The UDIOC enables clear visualization of microvasculature as small as ≈140 µm in diameter under UHF MRI, extending the detection limit of the 7 T MR angiography. Moreover, by virtue of high-resolution UHF MRI and a simple double-checking process, UDIOC-based dual-mode dynamic contrast-enhanced MRI is successfully applied to detect tumor vascular permeability with extremely high sensitivity and accuracy, providing a novel paradigm for the precise medical diagnosis of vascular-related diseases.Entities:
Keywords: DCE-MRI; MRI contrast agents; dual-mode contrast agents; magnetic nanoparticles; vascular imaging
Year: 2020 PMID: 33263204 DOI: 10.1002/adma.202004917
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849